| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_766eae8ff319d5744cdadf9b32cf8baa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff00c9b919a7efd7f7df2ea02ed6b0ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d0446a5bd77c7da68216fc2e3f05d48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-28 |
| filingDate |
2006-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3596edaa7499901dd1a1d699acd00e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8bf257641de47cbdf6957840bfa2a89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e56140d9b2a5b53a5643fb6307227c6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29571f1b6a6f7021bbe311a1ebf1d1c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd46aee8dd40cd057e7ea9a884e514ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6b3c46903a4d2a285d098013d6d39d1 |
| publicationDate |
2012-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2006256369-B2 |
| titleOfInvention |
Novel salts of conjugated psychotropic drugs and processes of preparing same |
| abstract |
Novel chemical conjugates of a psychotropic drug residue and an amino-containing organic acid residue selected to reduce side effects induced by the psychotropic drug when administered per se, to enhance the therapeutic activity of the psychotropic drug and/or to exert anti-proliferative activity, in which the amino group is in the form of an acid addition salt thereof and which are characterized by high stability are disclosed. Further disclosed are processes for preparing the chemical conjugates and addition salts thereof, pharmaceutical compositions containing the chemical conjugates and methods utilizing the chemical conjugates for treating various medical conditions. |
| priorityDate |
2005-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |